BPC-157 + TB-500 Blend Pharmacokinetics
BPC-157 + TB-500 Blend half-life, absorption, routes of administration, and clearance.
Half-Life & Dosing Cadence
BPC-157 + TB-500 Blend has a reported elimination half-life of a compound-specific window. The half-life is the time it takes for blood levels to fall by half, and it's the single biggest driver of how often you dose. Shorter half-lives mean more frequent dosing and faster clearance if you stop; longer ones mean steadier levels but a slower washout.
Administration & Absorption
BPC-157 + TB-500 Blend is administered by subcutaneous injection (into the fat layer just under the skin). The primary route is subcutaneous. Subcutaneous delivery is absorbed steadily from the fat depot, giving smoother peaks than intramuscular dosing. Whichever route you use, rotate sites and follow sterile technique.
Onset & Clearance
Because of its a compound-specific window half-life, BPC-157 + TB-500 Blend reaches steady levels after a few consistent doses and clears the system within roughly four to five half-lives once you stop. Track how you respond over a defined block rather than judging any single dose, and give the compound enough consistent days before deciding whether it's working. This is educational information, not medical advice — review your protocol with a clinician.
Physicochemical and PK profile
- Storage
- Store the lyophilized vial refrigerated (2-8°C) or at -20°C, away from light. Once reconstituted, keep refrigerated at 2-8°C and use promptly.
References
- Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal. 2025. · Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM · 2025
- Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. · Lee E, Padgett B · 2021
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing · McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM · 2025
- Goldstein AL, Kleinman HK. Minireview: Crosstalk between thymosin β4 and the chemokine network. Ann N Y Acad Sci. 2015. · Martinez JO, Evangelopoulos M, Bhavane R, Acciardo S, Salvatore F, Liu X, Ferrari M, Tasciotti E · 2015
- Thymosin β4 Promotes Dermal Healing. · Kleinman HK, Sosne G · 2016
- Gene ResultTMSB4X thymosin beta 4 X-linked [ (human)] - NCBI
- Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study. · Lee E, Walker C, Ayadi B · 2024
- Philp D, Kleinman HK. Animal studies with thymosin β4, a multifunctional tissue repair and regeneration peptide. Ann N Y Acad Sci. 2012. · Meyer M, Elmer S, Jäncke L · 2012
- Biological activities of thymosin beta4 defined by active sites in short ... · Sosne G, Qiu P, Goldstein AL, Wheater M · 2010
- Chang CH, et al. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014. · Chang CH, Tsai WC, Hsu YH, Pang JH · 2014
- Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. · Lee E, Burgess K · 2025